Covered recipient · General Payments record
NATHAN HENRY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,554.87
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $346.85 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $244.72 | 11 |
| Acerta Pharma LLC | $33.53 | 2 |
| Lilly USA, LLC | $28.53 | 2 |
| Janssen Pharmaceuticals, Inc | $21.05 | 1 |
| Urgo Medical North America, LLC | $19.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.70 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105661282 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.83 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104607854 | CMS |
| Janssen Pharmaceuticals, Inc | $21.05 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078101450 | CMS |
| Lilly USA, LLC | $14.05 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135911277 | CMS |
| Lilly USA, LLC | $14.48 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135932820 | CMS |
| Novo Nordisk Inc | $15.32 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100232280 | CMS |
| Novo Nordisk Inc | $12.27 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100604382 | CMS |
| Novo Nordisk Inc | $11.31 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100287676 | CMS |
| Novo Nordisk Inc | $89.74 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100545152 | CMS |
| Novo Nordisk Inc | $15.61 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100356404 | CMS |
| Novo Nordisk Inc | $12.89 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100657673 | CMS |
| Novo Nordisk Inc | $14.38 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100579010 | CMS |
| Novo Nordisk Inc | $13.65 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100466424 | CMS |
| Novo Nordisk Inc | $21.93 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100581672 | CMS |
| Novo Nordisk Inc | $16.64 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100286210 | CMS |
| Novo Nordisk Inc | $20.98 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100450583 | CMS |
| Urgo Medical North America, LLC | $19.02 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149431097 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.